These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 33153205)

  • 1. A Rejection Gene Expression Score in Indication and Surveillance Biopsies Is Associated with Graft Outcome.
    Chamoun B; Caraben A; Torres IB; Sellares J; Jiménez R; Toapanta N; Cidraque I; Gabaldon A; Perelló M; Gonzalo R; O'Valle F; Moreso F; Serón D
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33153205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation in Early Kidney Allograft Surveillance Biopsies With and Without Associated Tubulointerstitial Chronic Damage as a Predictor of Fibrosis Progression and Development of De Novo Donor Specific Antibodies.
    García-Carro C; Dörje C; Åsberg A; Midtvedt K; Scott H; Reinholt FP; Holdaas H; Seron D; Reisæter AV
    Transplantation; 2017 Jun; 101(6):1410-1415. PubMed ID: 27163535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of Serial Protocol Biopsies Performed After 1 Year in Predicting Long-Term Kidney Allograft Function According to Histologic Phenotype.
    Zachariah MS; Dwivedi AK; Yip CS; Chang SS; Gundroo A; Venuto RC; Tomaszewski J; Patel SK; Sharma R
    Exp Clin Transplant; 2018 Aug; 16(4):391-400. PubMed ID: 29206090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptome Analysis in Renal Transplant Biopsies Not Fulfilling Rejection Criteria.
    Moreso F; Sellarès J; Soler MJ; Serón D
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32213927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiling of mRNA of interstitial fibrosis and tubular atrophy with subclinical inflammation in recipients after kidney transplantation.
    Fu Q; Liao M; Feng C; Tang J; Liao R; Wei L; Yang H; Markmann JF; Chen K; Deng S
    Aging (Albany NY); 2019 Jul; 11(14):5215-5231. PubMed ID: 31343413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene Expression in Biopsies of Acute Rejection and Interstitial Fibrosis/Tubular Atrophy Reveals Highly Shared Mechanisms That Correlate With Worse Long-Term Outcomes.
    Modena BD; Kurian SM; Gaber LW; Waalen J; Su AI; Gelbart T; Mondala TS; Head SR; Papp S; Heilman R; Friedewald JJ; Flechner SM; Marsh CL; Sung RS; Shidban H; Chan L; Abecassis MM; Salomon DR
    Am J Transplant; 2016 Jul; 16(7):1982-98. PubMed ID: 26990570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transitional B cell cytokines risk stratify early borderline rejection after renal transplantation.
    Cherukuri A; Abou-Daya KI; Chowdhury R; Mehta RB; Hariharan S; Randhawa P; Rothstein DM
    Kidney Int; 2023 Apr; 103(4):749-761. PubMed ID: 36436679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA regulation in blood cells of renal transplanted patients with interstitial fibrosis/tubular atrophy and antibody-mediated rejection.
    Matz M; Heinrich F; Lorkowski C; Wu K; Klotsche J; Zhang Q; Lachmann N; Durek P; Budde K; Mashreghi MF
    PLoS One; 2018; 13(8):e0201925. PubMed ID: 30102719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular phenotype of kidney transplant indication biopsies with inflammation in scarred areas.
    Halloran PF; Matas A; Kasiske BL; Madill-Thomsen KS; Mackova M; Famulski KS
    Am J Transplant; 2019 May; 19(5):1356-1370. PubMed ID: 30417539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in Urinary Microbiome Populations Correlate in Kidney Transplants With Interstitial Fibrosis and Tubular Atrophy Documented in Early Surveillance Biopsies.
    Modena BD; Milam R; Harrison F; Cheeseman JA; Abecassis MM; Friedewald JJ; Kirk AD; Salomon DR
    Am J Transplant; 2017 Mar; 17(3):712-723. PubMed ID: 27597148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The selective biomarker IL-8 identifies IFTA after kidney transplantation in blood cells.
    Matz M; Lorkowski C; Fabritius K; Wu K; Rudolph B; Frischbutter S; Brakemeier S; Gaedeke J; Neumayer HH; Mashreghi MF; Budde K
    Transpl Immunol; 2016 Nov; 39():18-24. PubMed ID: 27693310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The causes, significance and consequences of inflammatory fibrosis in kidney transplantation: The Banff i-IFTA lesion.
    Nankivell BJ; Shingde M; Keung KL; Fung CL; Borrows RJ; O'Connell PJ; Chapman JR
    Am J Transplant; 2018 Feb; 18(2):364-376. PubMed ID: 29194971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered Expression of MicroRNAs Following Chronic Allograft Dysfunction with Interstitial Fibrosis and Tubular Atrophy.
    Soltaninejad E; Nicknam MH; Nafar M; Sharbafi MH; Keshavarz Shahbaz S; Barabadi M; Yekaninejad MS; Bahrami T; Ahmadpoor P; Amirzargar A
    Iran J Allergy Asthma Immunol; 2015 Dec; 14(6):615-23. PubMed ID: 26725559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining Blood Gene Expression and Cellfree DNA to Diagnose Subclinical Rejection in Kidney Transplant Recipients.
    Park S; Guo K; Heilman RL; Poggio ED; Taber DJ; Marsh CL; Kurian SM; Kleiboeker S; Weems J; Holman J; Zhao L; Sinha R; Brietigam S; Rebello C; Abecassis MM; Friedewald JJ
    Clin J Am Soc Nephrol; 2021 Oct; 16(10):1539-1551. PubMed ID: 34620649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicentre randomised controlled trial protocol of urine CXCL10 monitoring strategy in kidney transplant recipients.
    Ho J; Sharma A; Kroeker K; Carroll R; De Serres S; Gibson IW; Hirt-Minkowski P; Jevnikar A; Kim SJ; Knoll G; Rush DN; Wiebe C; Nickerson P
    BMJ Open; 2019 Apr; 9(4):e024908. PubMed ID: 30975673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the Current Versus the Previous Diagnostic Threshold on the Outcome of Patients With Borderline Changes Suspicious for T Cell-mediated Rejection Diagnosed on Indication Biopsies.
    McRae M; Bouchard-Boivin F; Béland S; Noël R; Côté I; Lapointe I; Lesage J; Latulippe E; Riopel J; Santoriello D; Husain SA; Désy O; Houde I; Batal I; De Serres SA
    Transplantation; 2018 Dec; 102(12):2120-2125. PubMed ID: 29916985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal graft survival according to Banff 2013 classification in indication biopsies.
    Arias-Cabrales C; Redondo-Pachón D; Pérez-Sáez MJ; Gimeno J; Sánchez-Güerri I; Bermejo S; Sierra A; Burballa C; Mir M; Crespo M; Pascual J
    Nefrologia; 2016; 36(6):660-666. PubMed ID: 27595515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-free microRNA-148a is associated with renal allograft dysfunction: Implication for biomarker discovery.
    Nariman-Saleh-Fam Z; Bastami M; Ardalan M; Sharifi S; Hosseinian Khatib SM; Zununi Vahed S
    J Cell Biochem; 2019 Apr; 120(4):5737-5746. PubMed ID: 30320905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subclinical rejection associated with chronic allograft nephropathy in protocol biopsies as a risk factor for late graft loss.
    Moreso F; Ibernon M; Gomà M; Carrera M; Fulladosa X; Hueso M; Gil-Vernet S; Cruzado JM; Torras J; Grinyó JM; Serón D
    Am J Transplant; 2006 Apr; 6(4):747-52. PubMed ID: 16539631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular diagnostics identifies risks for graft dysfunction despite borderline histologic changes.
    Hrubá P; Brabcová I; Gueler F; Krejčík Z; Stránecký V; Svobodová E; Malušková J; Gwinner W; Honsová E; Lodererová A; Oberbauer R; Zachoval R; Viklický O
    Kidney Int; 2015 Oct; 88(4):785-95. PubMed ID: 26176825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.